Renal deposits of complement factors as predictors of end-stage renal disease and death in patients with lupus nephritis

Abstract Objective Lupus nephritis (LN) increases the risks of end-stage renal disease (ESRD) and death, but these risks are difficult to estimate. Since complement factors play an essential role in the pathogenesis and are deposited in the kidneys as C1q and C3, we studied whether these deposits predict ESRD and death in patients with LN. Methods We collected demographic, clinical and pathological data from 183 adult patients with LN classes II–V diagnosed with a first native kidney biopsy. Pathological data included the localization and intensity of immunofluorescence staining of C1q and C3. We obtained dates of incident ESRD and death from the United States Renal Data System and National Death Index, respectively, and evaluated survival curves and hazard ratios for ESRD and death as a composite outcome and as separate outcomes. Results The presence and intensity of deposits of C1q and C3 in glomeruli, tubular walls and vascular walls differed between classes and were associated with known unfavourable prognostic factors, such as hypertension, hypoalbuminemia and hypocomplementemia. However, over a median follow-up of 7.5 years, their presence and intensity were associated with neither survival free of ESRD and death nor hazard ratios for ESRD and death. Conclusion Renal deposits of complement factors did not predict ESRD and death in patients with LN.

[1]  Paul J. Hoover,et al.  Clinical characteristics and renal prognosis associated with interstitial fibrosis and tubular atrophy (IFTA) and vascular injury in lupus nephritis biopsies. , 2019, Seminars in arthritis and rheumatism.

[2]  B. Julian,et al.  The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy , 2019, Front. Immunol..

[3]  K. Seyb,et al.  Glomerular membrane attack complex is not a reliable marker of ongoing C5 activation in lupus nephritis , 2019, Kidney International.

[4]  Hyon K. Choi,et al.  All‐Cause and Cause‐Specific Mortality Trends of End‐Stage Renal Disease Due to Lupus Nephritis From 1995 to 2014 , 2019, Arthritis & rheumatology.

[5]  G. Xing,et al.  Tubular basement membrane immune complex deposition is associated with activity and progression of lupus nephritis: a large multicenter Chinese study , 2018, Lupus.

[6]  B. Rovin,et al.  Update on Lupus Nephritis. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[7]  J. Wren,et al.  Systemic lupus erythematosus biomarkers: the challenging quest , 2016, Rheumatology.

[8]  M. Ward,et al.  Risk of End‐Stage Renal Disease in Patients With Lupus Nephritis, 1971–2015: A Systematic Review and Bayesian Meta‐Analysis , 2016, Arthritis & rheumatology.

[9]  Anhar Ullah,et al.  Prognostic significance of C1q deposition in serial biopsies for predicating the long-term outcome in patients with proliferative lupus nephritis. , 2016, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[10]  A. Davidson What is damaging the kidney in lupus nephritis? , 2016, Nature Reviews Rheumatology.

[11]  B. Rovin,et al.  Characterising the immune profile of the kidney biopsy at lupus nephritis flare differentiates early treatment responders from non-responders , 2015, Lupus Science & Medicine.

[12]  D. Birmingham,et al.  The Complement System in Lupus Nephritis. , 2015, Seminars in Nephrology.

[13]  Alan B Leichtman,et al.  US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  B. Rovin,et al.  Predictors of Long‐Term Renal Outcome in Lupus Nephritis Trials: Lessons Learned from the Euro‐Lupus Nephritis Cohort , 2015, Arthritis & rheumatology.

[15]  Yoshiya Tanaka,et al.  Low complements and high titre of anti-Sm antibody as predictors of histopathologically proven silent lupus nephritis without abnormal urinalysis in patients with systemic lupus erythematosus. , 2015, Rheumatology.

[16]  Kwan-Kyu Park,et al.  Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways. , 2013, International journal of clinical and experimental pathology.

[17]  Ming-hui Zhao,et al.  Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis , 2013, BMC Nephrology.

[18]  Glomerular C4d Staining Can Be an Indicator of Disease Activity in Lupus Nephritis , 2013, Renal failure.

[19]  T. Utset,et al.  Predicting outcomes of lupus nephritis with tubulointerstitial inflammation and scarring , 2011, Arthritis care & research.